Table 1 also shows the differences between the DM patients using sulfonylureas or biguanides and those DM patients who are not using sulfonylureas or biguanides as follows, including the insulin injection, alpha glucosidase inhibitors, thiazolidinediones, or DPP-4 inhibitors (all p < 0.001). This evidence concerns the gene DPP4 and diabetes mellitus.